|1.||Kamitani, Akiyo: 1 article (09/2010)|
|2.||Kanai, Kenichi: 1 article (09/2010)|
|3.||Yasuda, Kunio: 1 article (09/2010)|
|4.||Han, Song-iee: 1 article (09/2010)|
|5.||Kataoka, Kohsuke: 1 article (09/2010)|
|6.||Hamazaki, Yuri: 1 article (09/2010)|
|7.||Reza, Hasan Mahmud: 1 article (09/2010)|
|8.||Hirayama, Kouichi: 1 article (11/2009)|
|9.||Kobayashi, Masaki: 1 article (11/2009)|
|10.||Tanaka, Hiromi: 1 article (11/2009)|
08/01/2009 - "Musculoaponeurotic fibrosarcoma oncogene (MAF) transcription factors play an important role in cell proliferation, differentiation and survival; therefore, regulation of these genes may be a major mechanism employed by T. "
08/01/2009 - "The protozoan parasite Theileria annulata alters the differentiation state of the infected macrophage and suppresses musculoaponeurotic fibrosarcoma oncogene (MAF) transcription factors."
04/15/2005 - "Both nuclear factor erythroid 2 45 kDa subunit (p45) and BTB and CNC homolog 1 (Bach) transcription factors can form dimers with one of the small Maf proteins, and these heterodimers bind to the musculoaponeurotic fibrosarcoma oncogene (Maf) recognition element (MARE). "
02/01/2007 - "The transcription factor nuclear factor E2 p45-related factor 2 (Nrf2) forms heterodimers with small musculoaponeurotic fibrosarcoma (Maf) proteins for the selective recognition of the antioxidant responsive element on target genes, followed by the regulation of gene expression of phase II detoxifying enzymes as well as oxidative-stress-inducible proteins in different tissues. "
|5.||Acute Erythroblastic Leukemia (Erythroleukemia)
08/28/2001 - "We have performed chromatin immunoprecipitation experiments to determine the recruitment of the erythroid-specific transactivator p45 NF-E2/MafK (p18 NF-E2) heterodimer and small Maf proteins to various regions in the globin gene locus before and after the induction of murine erythroleukemia (MEL) cell differentiation. "
|1.||Transcription Factors (Transcription Factor)
|2.||Proteins (Proteins, Gene)
|3.||Trans-Activators (Trans-Acting Factor)